• ´ëÅðÁ÷±Ù¿¡ ¹ß»ýÇÑ »ç±¸Á¾

• Glomus Tumor in Rectus Femoris; I case report

• À̼ºÅ ( Lee Sung-Tae )

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  678 ~ 682

• Maffucci¾¾ ÁõÈıº¿¡ ¼Ó¹ßÇÑ ¿¬°ñÀ°Á¾

• Secondary Chondrosarcoma in Maffucci¡¯s Syndrome; A case report

• À̼ºÅ ( Lee Sung-Tae )

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  674 ~ 677

• Á÷Àå¿ëÁ¾À» µ¿¹ÝÇÑ µ¿½Ã¼º °áÀå »ïÁߺ¹ ¾Ç¼ºÁ¾¾ç

• A Treble Synchronous Colonic Carcinoma with a Rectal Polyp

• ±èÇü¿¬

• ¼­µ¿¿±/°­Áø±¹/¹Ú¾çÈñ/°­¹®ÀÚ

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  667 ~ 673

• ¾ÏÀÇ °¡Á·ÁýÀû¼º¿¡ °üÇÑ ¿ªÇÐÀû ¿¬±¸

• Epidemiological Studies on Familial Aggregation of Selected Cancers

• ÀÌÁø¿À

• ½ÉÀ±»ó, ÃÖ¼ö¿ë

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  658 ~ 666

• ¿¬ºÎ Á¶Á÷ À°Á¾ÀÇ ÀÓ»óÀû ¿¬±¸

• Clinical Study of Soft Tissue Sarcoma

• À̱⼮

• ÃÖ°æÇö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  648 ~ 657

• ¼Ò¾Æ ¹× 10´ëÀÇ °©»ó¼± ¾Ï

• A 20 Year, Experience with Well Differetiated Thyroid Carcinoma in Children & Teenagers

• À¯°èÁØ

• Àå¹Ì¼÷, ÀÌ¿ë¹è

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  640 ~ 647

• ÁÖŸ¾×¼± Á¾¾çÀÇ ÀÓ»óÀû °íÂû

• A Clinical Study of Major Salivary Gland Tumors

• ȲÀÇ¿Ï

• À̹«¿ë

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  630 ~ 639

• ´ëÀå ¹× Á÷Àå¾ÏÀÇ ¿¹ÈÄ ÀÎÀÚ¿¡ °üÇÑ ÀÓ»óÀû ¿¬±¸

• Clinical Study for Prognostic Factors in Colorectal Cancer

• ÀÌö±Ô

• ¹é³²¼±, ÃÖµ¿¿í

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  619 ~ 629

• À§Àå°ü ÆòÈ°±ÙÀ°Á¾ÀÇ ÀÓ»óÀû °íÂû

• A Clinical Study of Leiomyosarcomas of Gastrointestinal Tract

• ÀÌÈ­¿µ

• ³ëÀç°æ/Á¤Çöö/±èµ¿¸³/ÀÓÈ£¿µ/°íÀºÈñ/±èÁÖÇ×/ÁöÈÆ»ó/±èº´¼ö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  606 ~ 618

• À§ÀÇ À¯¾ÏÁ¾

• Gastric Carcinoid Tumor

• ±è¿Ï¼ö

• ÃÖ½ÂÈ£/³ë¼ºÈÆ/¹ÎÁø½Ä/±èÈ£±Ù/±è¿øÈ£

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  596 ~ 605

• Á¦2±â À§¾Ï ȯÀÚ¿¡¼­ÀÇ ¿¹ÈÄÀÎÀÚ¿¡ ´ëÇÑ ´Ùº¯·® ºÐ¼®

• Mutivariate Analysis of Prognostic Factors in Stage II Gastric Cancer Patients

• ¹Î¾ç±â

• ¿À¼ºÅÂ, À̼öÀÏ

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  586 ~ 595

• ÀÜÀ§¾Ï

• Remnant Stomach Cancer

• ³ë¼ºÈÆ

• À±µ¿¼·/ÃÖ½ÂÈ£/¹ÎÁø½Ä/³ëÀç°æ/±èº´¼ö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  578 ~ 585

• ¸Þ½Ã¸¶ EX»êÀ» ÀÌ¿ëÇÑ ¼ÒÈ­±â¾Ï ¸é¿ª¿ä¹ý

• Immunotherapy with "Mesima EX" in the Treatments of Digestive Cancers

• À̺ÀÈ­

• È«±âõ/Á¶¿ë°ü/À̵μ±/¾çÁ¤Çö/ÃÖ°æ¿ì/±èÁ¾È«/¿ìÁ¦È«/ÀÌÂù¿µ

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  571 ~ 577

• ÁøÇ༺ ¹× Àç¹ß¼º ´ëÀå¾Ï¿¡¼­ 5-Fluorouracil°ú Àú¿ë·® Leucovorin º´¿ë¿ä¹ý¿¡ ´ëÇÑ Á¦II»ó ÀÓ»ó ¿¬±¸

• 5-Fluorouracil and Low dose leucovorin in Advanced Colorectal Carcinoma

• ÀÓÈ£¿µ

• Á¤Çöö/ÃÖÁøÇõ/À¯³»Ãá/±èµ¿¸³/°íÀºÈñ/±èÁÖÇ×/³ëÀç°æ/±èº´¼ö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  563 ~ 570

• ºÎÀΰúÁ¾¾ç ȯÀÚ¿¡¼­ Tumor-associated Trypsin Inhibitor(TATI) ÃøÁ¤¿¡ °üÇÑ ¿¬±¸

• Tumor-Associated Trypsin Inhibitor(TATI) in Gynecologic Tumors

• ±èÁö¿¬

• ¾öÇпµ, ±è¿¬¼ö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  554 ~ 562

• Chloroform ¸¸¼º Áßµ¶À¸·Î ÀÎÇÑ °£º´º¯¿¡ ´ëÇÑ º´¸®ÇÐÀû ¿¬±¸

• Pathologic Studies on Chronic Hepatic Lesions Induced by Chloroform

• Á¤È£¼®

• °­´ë¿µ

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  544 ~ 553

• HL-60 ¼¼Æ÷ÀÇ ºÐÈ­¿¡ µû¸¥ Ç׿øÀÇ º¯È­¿¡ °üÇÑ ¿¬±¸

• Expression of Antigens During HL-60 Cell Differentiation

• ¿ÀÁ¾¼®

• °­ÀÎö/·ùÇÊ¿­/½ÅºÎ¾È/ÀÌÇöö

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  536 ~ 543

• ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ ȯÀÚ¿¡ À־ Áúº´ÀÇ ½Ã±â¿¡ µû¸¥ c-fmsÀÇ Ç¥Çö¾ç»ó

• Expression of c-fms in Each Stage of Chronic Myelogenous Leukemia

• ¹ÚÁ¾¿ø

• ¾çÀÏÈ£/ÇÑÄ¡È­/ÀÌÁ¾¿í/¹Î¿ì¼º/±èÃáÃß/±è¿øÀÏ/±èµ¿Áý

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  529 ~ 535

• Á÷Àå S»ó °áÀåÇϺΠ¾Ç¼ºÁ¾¾çÀÇ c-myc¹× c-Ha-ras¾ÏÀ¯ÀüÀÚÀÇ ¹ßÇö

• Expressions of c-myc and c-Ha-ras Oncogenes in Rectosigmoid Cancer and Rectal Cancer

• ¹è¿Á¼®

• ¹Ú¼º´ë, À̱¤¼®, ÀÓÁ¤±Ù

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  524 ~ 528

• 1, 2 DMH¿¡ ÀÇÇØ À¯¹ßµÈ Wistar rat ´ëÀå¾Ï À¯ÀüÀÚÀÇ ¹ßÇö

• Expression of c-myc Oncogene in 1-2 DMH Induced Colon Cancer of Wistar rats

• Â÷±¤±¹

• ¹è¿Á¼®, À̱¤¼®

• ´ëÇѾÏÇÐȸÁö   1991³â  23±Ç  3È£  518 ~ 523